OR WAIT null SECS
November 15, 2017
The use of therapeutic vaccines presents a new way to manage diseases, such as cancer and sexually transmitted diseases.
A new facility type integrates next-generation mobile cleanroom systems.
November 14, 2017
ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.
November 13, 2017
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
November 03, 2017
CDMO Celonic acquired a biomanufacturing facility in Heidelberg, Germany from Glycotope.
November 02, 2017
The companies will collaborate to develop and manufacture Grid’s lead therapeutic candidate for the treatment of solid tumors.
October 27, 2017
As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.
AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.
October 25, 2017
ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.